Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 28, 2022 08:00 ET | Source: Certara

Certara Announces Collaboration with Leading Cancer Center to Advance CAR T-cell Therapies

PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a 2-year collaboration with Memorial Sloan Kettering Cancer Center...
July 25, 2022 08:00 ET | Source: Certara

Certara Appoints Rosemary Crane as New Independent Board Member

PRINCETON, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Rosemary Crane to its Board of Directors,...
July 13, 2022 08:00 ET | Source: Certara

Certara Appoints Eran Broshy as New Independent Board Member

PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Eran Broshy to its Board of Directors, effective...
July 12, 2022 08:00 ET | Source: Certara

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of...
June 28, 2022 08:00 ET | Source: Certara

Certara Introduces New Simcyp™ Discovery Simulator for Early-Stage and Translational Drug Development

PRINCETON, N.J., June 28, 2022 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Discovery Simulator, a new software designed for...
June 21, 2022 08:00 ET | Source: Certara

Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics

PRINCETON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Certara Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG),...
May 05, 2022 16:15 ET | Source: Certara

Certara Reports First Quarter 2022 Financial Results

PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2022. ...
May 03, 2022 16:30 ET | Source: Certara

Certara to Participate in Upcoming Investor Conferences

PRINCETON, N.J., May 03, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor...
April 20, 2022 08:00 ET | Source: Certara

Certara to Report First Quarter 2022 Financial Results on May 5th, 2022

PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of...
March 01, 2022 16:15 ET | Source: Certara

Certara Reports Fourth Quarter and Full Year 2021 Financial Results

PRINCETON, N.J., March 01, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter and full year of 2021...